The Cigna Group stock lifts outlook after strong third quarter

The Cigna Group raised its 2026 adjusted earnings outlook after reporting stronger third-quarter operations on Thursday, November 5. In its earnings release, the company said total revenue rose 6 percent year over year to 73.7 billion dollars.

Adjusted income from operations reached 2.1 billion dollars, or 7.98 dollars per share, compared with 7.83 dollars a year earlier. Reported shareholders' net income fell to 1.4 billion dollars, or 5.47 dollars per share, from 1.9 billion dollars, or 6.98 dollars, because the prior-year period included an after-tax gain on a business sale.

Healthcare segment drives the upgrade

Cigna Healthcare was the main earnings growth engine. The segment's adjusted revenue increased 9 percent to 11.7 billion dollars, while adjusted pretax income rose 15 percent to 1.2 billion dollars. The company attributed the improvement primarily to higher net investment income and better operating efficiency.

Evernorth Health Services produced adjusted revenue of 63.8 billion dollars, up 6 percent. Adjusted pretax income declined 4 percent to 1.8 billion dollars, as Pharmacy Benefit Services earnings fell 22 percent to 765 million dollars amid large client contract renewals and strategic investments. Specialty and Care Services partly offset that pressure with 15 percent earnings growth to 1.1 billion dollars.

Total medical customers increased 2 percent from December 2025 to 18.5 million at the end of September. Total customer relationships declined 6 percent to 177.6 million, mainly because of lower pharmacy and behavioral customers. The company said the reduction in behavioral customers followed the termination of a government contract and had minimal impact on revenue and adjusted income.

Higher guidance sets the next benchmark

Management raised the full-year 2026 adjusted income from operations outlook by 0.15 dollars per share to at least 30.60 dollars. The outlook includes expected future share repurchases and anticipated 2026 dividends. The company also lifted its Cigna Healthcare pretax earnings floor by 50 million dollars to at least 4.6 billion dollars, while maintaining the Evernorth target at at least 6.9 billion dollars.

The outlook strengthens the near-term earnings case, but investors still face execution risks in pharmacy benefits and the planned exit from the Individual and Family Plans medical business on January 1, 2027. Cigna Healthcare's medical care ratio outlook was narrowed to 84.2 percent plus or minus 25 basis points, keeping medical-cost trends central to the valuation debate.

The Cigna Group stock traded at 270.25 euros on Lang & Schwarz at 1:51 p.m. CET on Wednesday, November 11, 2.80 percent above the Xetra close of 267.50 euros on Tuesday, November 10.

The S&P 500 provides the broader market backdrop for U.S.-listed healthcare shares.

More news and analyses on The Cigna Group stock.